Post hoc analysis with Bonferroni correction revealed no significant difference between Sessions 1 and 2 ( p = 0.574), but accuracy in Session 3 showed a trend toward improvement compared with Sessions 1 ( p = 0.053) and 2 ( p = 0.081), although these did not reach the corrected significance threshold.
Patients with higher body mass index showed a trend towards lower mortality, which did not meet the level of statistical significance (OR 0.9, 95% CI 0.9 1.0, P = 0.053).
CMR area-length showed a trend to overestimation of the LA volume in SR (p=0.053) but not in AF (p=0.927).
Notably, estriol use during radiotherapy showed a trend toward reducing subjective vaginal dryness (r=–0.297, p =0.053), highlighting its potential role in mitigating vaginal toxicity.
Although not statistically significant, higher TGF-β levels at three months post-treatment initiation showed a trend toward association with worse outcomes [mean (standard deviation) 43.2 (28.2) pg/mL vs. 29.6 (46.9) pg/mL, p = 0.053] ( Figure 5 ).
Lymphovascular invasion (LVI) and pN1 showed a trend toward poor DFS (LVI, p=0.053; pN1, p=0.059).
The Reward*Time*Group ANOVA revealed that reaction times differed significantly between coin and circle (main effect Condition: F (1, 82) = 22.78, p < .001, see Fig 1C ) and showed a trend-wise decrease following a reversal (main effect Time: F (3, 246) = 2.6, p = .053).
In this small group, the mean baseline RSAD2 expression in the basophils showed a trend toward higher expression compared to the poor/non-responder group (p=0.053, Supplementary Figure S5A ).
Current residents (43%) showed a trend toward higher completion rates than recently graduated specialists (19%; p = 0.053), with a mean of 2.3 EPAs completed (range 1–5).
Patients treated with combination therapy showed a trend toward a longer PFS if an irAE was documented [9.7 months vs. 7.1 months, (HR, 0.50; 95% CI, 0.25–1.02; P = 0.053); Fig. 1 c].
Univariate analyses using the cox regression analysis ( Tables S1 – S5 ) revealed that recurrence was a significant prognosticator for PFS (HR, 3.986; 95% CI: 1.246–12.754, p = 0.020); salvage IMRT is a significant predictor for PFS (HR, 3.009; 95% CI: 1.007–8.991, p = 0.049); the use of ENI significantly improves LPFS (HR, 0.136; 95% CI: 0.019–0.964, p = 0.046); recurrence showed a trend to predict DMFS (HR, 5.373; 95% CI: 0.981–29.426, p = 0.053), and OS (HR, 5.886; 95% CI: 0.931–37.231, p = 0.060); salvage IMRT showed a trend to predict LPFS (HR, 5.840; 95% CI: 0.821–41.522, p = 0.078).
Within-group tests showed that participants in the WA-MBP-LS group significantly improved on JSS at posttest (B = 1.84, 95% CI = 0.19–3.49, d = 0.42, z = 2.19, p = 0.029), and they showed a trend very close to significance and of similar ES at follow-up (B = 1.94, 95% CI = −0.03–3.90, d = 0.48, z = 1.94, p = 0.053).
In analyses of the correlation of mutation status of CTNNB1 and efficacy of meloxicam treatment, mutation status showed a trend to associate with efficacy (p = 0.053, Table 2 ).
At 110 d, anemic sows showed a trend toward elevated levels of butyrate ( P = 0.053) and isovalerate (Table 4 , P = 0.068).
The decrease in Y-BOCS scores in the glycine compared to the placebo group showed a trend not reaching significance (p=0.053).
3 , compared to the CON group, HDCA enhanced the protein expression of TGR5 in abdominal fat and backfat ( P < 0.05), and LCA showed a trend towards enhancing PPARG protein expression ( P = 0.053) in abdominal fat and significantly enhanced PPARG protein expression ( P < 0.001) in backfat of finishing pigs. 3.7 HDCA reduced the adipogenesis in 3T3-L1 mature adipocytes The results above showed that HDCA tended to reduce backfat thickness and improved carcass quality in finishing pigs compared to LCA.
In addition, the HC participants who performed the DG task also showed a trend toward the KYNA/KYN ratio ( r = −0.334, P = 0.053).
The performance on the discrimination index of the novel object and the displaced object showed a trend between groups [NOR: F (3, 36) = 2.818, p = 0.053], SOR: [ F (3, 34) = 2.775, p = 0.056].
The multilevel linear regression model showed a trend towards increased γ-H2AX levels in responders [1.17, 95% confidence interval (CI): −0.02 to 2.34, P=0.053].
Among the genes tested only BnipL3 was downregulated (P = 0.0018) while Hspe1 showed a trend for lower level (P = 0.053) in IVC groups compare to control (Fig. 6 A).
Further, analysis of mRNA levels of SOX11 and SAMHD1 in sorted MCL cells ( N = 19) showed a trend for correlation (Spearman correlation coefficient 0.45, P = 0.053).
Adding the main effect of group to the LMM for the learning rate showed a trend for the main effect of group on the learning rate ( F (1,109) = 3.83, p = .053; η 2 p = .03, 95% CI [.00, 1.00]).
For ELISA, the dementia group showed a trend of lower Aβ1-42/Aβ1-40 (0.051 ± 0.021 vs. 0.062 ± 0.022, p = 0.053) and higher t-Tau (594 ± 502 vs. 313 ± 145, p = 0.028) and p181Tau (81 ± 46 vs. 56 ± 22, p = 0.034) than the MCI group.
In the univariate analysis of the first-line setting, luminal A subtype showed a trend towards a correlation with a longer PFS ( p = 0.053).
The difference between the medicated and control groups showed a trend toward higher weight [ t 36 = 3.571, P = 0.053].